Pathstone Holdings, LLC Neurocrine Biosciences Inc Transaction History
Pathstone Holdings, LLC
- $21.2 Billion
- Q1 2024
A detailed history of Pathstone Holdings, LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Pathstone Holdings, LLC holds 5,337 shares of NBIX stock, worth $777,547. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,337
Previous 6,368
16.19%
Holding current value
$777,547
Previous $839,000
12.28%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NBIX
# of Institutions
632Shares Held
94.5MCall Options Held
472KPut Options Held
245K-
Black Rock Inc. New York, NY13.8MShares$2 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.93MShares$1.45 Billion0.03% of portfolio
-
State Street Corp Boston, MA3.99MShares$581 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY2.3MShares$334 Million0.03% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.25MShares$328 Million0.49% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.9B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...